BlackRock Health Sciences Term Trust (NYSE:BMEZ) Sees Large Decline in Short Interest

BlackRock Health Sciences Term Trust (NYSE:BMEZ) saw a large decrease in short interest during the month of February. As of February 27th, there was short interest totaling 12,573 shares, a decrease of 33.8% from the February 12th total of 18,985 shares. Based on an average trading volume of 218,685 shares, the short-interest ratio is presently 0.1 days. Based on an average trading volume of 218,685 shares, the short-interest ratio is presently 0.1 days.

BlackRock Health Sciences Term Trust Price Performance

BlackRock Health Sciences Term Trust stock traded down $0.21 during trading hours on Friday, hitting $13.96. The stock had a trading volume of 239,647 shares, compared to its average volume of 288,493. The business’s 50 day simple moving average is $15.08 and its 200-day simple moving average is $14.92. BlackRock Health Sciences Term Trust has a one year low of $12.58 and a one year high of $15.80.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be paid a $0.11 dividend. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) annualized dividend and a dividend yield of 9.5%.

Insider Buying and Selling at BlackRock Health Sciences Term Trust

In related news, Director Robert W. Fairbairn sold 10,294 shares of the firm’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $14.98, for a total transaction of $154,204.12. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Hedge funds have recently added to or reduced their stakes in the business. Kestra Advisory Services LLC bought a new stake in BlackRock Health Sciences Term Trust during the 4th quarter worth approximately $26,000. Geneos Wealth Management Inc. acquired a new position in BlackRock Health Sciences Term Trust in the 1st quarter valued at approximately $40,000. Allworth Financial LP raised its stake in shares of BlackRock Health Sciences Term Trust by 24,584.6% during the third quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after acquiring an additional 3,196 shares during the last quarter. CWM LLC lifted its holdings in shares of BlackRock Health Sciences Term Trust by 25.6% during the fourth quarter. CWM LLC now owns 3,336 shares of the company’s stock worth $50,000 after purchasing an additional 680 shares during the period. Finally, Newbridge Financial Services Group Inc. acquired a new position in shares of BlackRock Health Sciences Term Trust during the second quarter worth $69,000.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.